Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results

Simulations Plus, Inc. ("Simulations Plus"), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its second quarter fiscal 2024, ended February 29, 2024....

Related Keywords

United States ,America ,Asia Pacific ,Shawn Oconnor ,Linkedinx Youtube ,Company Adjusted ,Company Board Of Directors ,Services Performance Metrics ,Exchange Commission ,Software Performance Metrics ,Nasdaq ,Simulations Plus Inc ,Conference Call ,Plus Reports Second Quarter Fiscal ,Shawno Connor ,Chief Executive Officer ,Clinical Pharmacology ,Artificial Intelligence ,Quantitative Systems Pharmacology ,Physiologically Based Pharmacokinetics ,Simulations Plus ,Will Frederick ,Conference Calls ,Adjusted Diluted ,